Calendar Galecto, Inc.

Equities

GLTO

US36322Q1076

Delayed Nasdaq Other stock markets 19:58:31 30/04/2024 BST			5-day change	1st Jan Change
0.685 ^USD	-2.38%		-2.23%	-4.86%

03-08	Galecto, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Galecto Shares Climb After Bone Marrow Disease Treatment Trial Yields Positive Results	MT

Chart calendar Galecto, Inc.

7e0530238351b4b0e1926c03a3770e.vb62ehJyQFcF_ictzGdpIML78gpzdy3WmvKpkSSRGtw.-M33ICQTc2dCllRr-ipQdpODgkg3Okjj2YfBo0n5V7rI74RIWjE0M0_LEw~d29ead499039766a5b3667782017b53a

Upcoming events on Galecto, Inc.

30/07/2024

Q2 2024 Earnings Release (Projected)

Past events on Galecto, Inc.

25/04/2024	Q1 2024 Earnings Release (Projected)
27/09/2023 21:45	Cantor Global Healthcare Conference
11/09/2023 12:00	H.C. Wainwright Global Investment Conference
31/07/2023 21:05	Q2 2023 Earnings Release
14/06/2023 14:00	Annual General Meeting
08/06/2023 21:00	Jefferies Global Healthcare Conference
21/05/2023 14:00	ATS International Conference - Session: A67
28/04/2023 13:00	Q1 2023 Earnings Release
18/04/2023 14:00	American Association for Cancer Research Meeting - Abstract Number:LB173
17/04/2023 14:00	American Association for Cancer Research Meeting - Abstract Number:LB104
13/03/2023 13:20	Oppenheimer Healthcare Conference
09/03/2023 12:00	Q4 2022 Earnings Release
14/02/2023 13:00	SVB Securities Global Biopharma Conference
10/12/2022 23:30	American Society of Hematology Meeting
16/11/2022 07:25	Jefferies London Healthcare Conference
08/11/2022 15:30	American Association for the Study of Liver Diseases Meeting - Abstract Number:5014
08/11/2022 14:15	Q3 2022 Earnings Release
08/11/2022 13:00	Guliver-2 Phase 1b/2a Results Call
07/11/2022 18:00	American Association for the Study of Liver Diseases Meeting - Abstract Number:38895
06/11/2022 18:00	American Association for the Study of Liver Diseases Meeting - Abstract Number:3627

Annual results

Fiscal Period	December	2019	2020	2021	2022	2023	2024
Net sales Million USD	Released Forecast Spread	0,00	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00
EBITDA Million USD	Released Forecast Spread	0,00	-33,4 -40,3 16.98%	-51,8 -54,3 4.66%	-60,7 -66,6 8.9%	0,00 0,00 -	0,00
EBIT Million USD	Released Forecast Spread	-39,0	-33,6 -38,4 12.41%	-52,2 -54,2 3.62%	-61,2 -66,7 8.21%	-39,9 -40,3 1.06%	-34,0
Earnings before Tax (EBT) Million USD	Released Forecast Spread	0,00	-34,8 -38,3 9.04%	-51,8 -53,3 2.9%	-61,6 -66,0 6.63%	-38,3 -38,5 0.47%	-33,7
Net income Million USD	Released Forecast Spread	0,00	-34,8 -40,6 14.27%	-51,8 -53,6 3.51%	-61,6 -64,5 4.53%	-38,3 -40,0 4.04%	-32,7
EPS USD	Released Forecast Spread	-421	-7,62 -5,10 -49.51%	-2,05 -2,13 3.76%	-2,43 -2,51 3.19%	-1,44 -1,51 4.64%	-1,20
Announcement Date		02/09/20	29/03/21	17/02/22	09/03/23	08/03/24	-

Quarterly results

Fiscal Period	December	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4
Net sales Million USD	Released Forecast Spread	0,00 0,00 -		0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00	0,00	0,00
EBITDA Million USD	Released Forecast Spread					-13,4 -18,4 27.43%
EBIT Million USD	Released Forecast Spread	-13,5 -14,6 7.75%		-17,1 -13,8 -24.25%	-13,6 -16,9 19.35%	-13,5 -18,4 26.61%	-13,5 -17,7 23.77%	-11,2 -14,9 24.86%	-5,86 -13,3 56.08%	-6,67 -7,10 6.02%
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-13,4 -14,3 6.23%					-13,0 -17,7 26.59%	-10,7 -14,9 27.65%	-8,14 -13,1 38.06%	-6,48 -6,66 2.72%
Net income Million USD	Released Forecast Spread	-13,4 -14,3 6.23%	-16,9	-16,9 -17,3 2.39%	-13,7 -17,3 20.64%	-14,1 -14,5 2.97%	-13,0 -16,1 19.04%	-10,7 -14,9 27.65%	-8,14 -12,7 36.06%	-6,48 -8,42 23.09%	-5,48 -11,3 51.53%	-10,5	-4,80	-4,30
EPS USD	Released Forecast Spread	-0,53 -0,56 5.36%	-0,67	-0,67 -0,69 2.9%	-0,54 -0,68 20.59%	-0,55 -0,57 3.51%	-0,51 -0,63 18.4%	-0,41 -0,59 30.11%	-0,30 -0,47 36.17%	-0,23 -0,31 25.81%	-0,20 -0,29 31.03%	-0,25	-0,14	-0,12
Announcement Date		17/02/22	29/04/22	29/07/22	08/11/22	09/03/23	28/04/23	31/07/23	06/11/23	08/03/24	29/04/24	-	-	-

Upcoming sector events for Galecto, Inc.

Today 21:05	EXELIXIS, INC.: Q1 2024 Earnings Release
30/04/2024	SUMMIT THERAPEUTICS INC.: Q1 2024 Earnings Release
30/04/2024	MACROGENICS, INC.: Q1 2024 Earnings Release (Projected)
30/04/2024	REGENXBIO INC.: Q1 2024 Earnings Release (Projected)
30/04/2024	DECIPHERA PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected)
01/05/2024 12:00	NEUROCRINE BIOSCIENCES, INC.: Q1 2024 Earnings Release
01/05/2024 21:05	SAREPTA THERAPEUTICS, INC.: Q1 2024 Earnings Release
01/05/2024	ZENTALIS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected)
01/05/2024	DENALI THERAPEUTICS INC.: Q1 2024 Earnings Release (Projected)
01/05/2024	GERON CORPORATION: Q1 2024 Earnings Release

More events

Past sector events for Galecto, Inc.

Today	DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
Today	ARVINAS, INC.: Q1 2024 Earnings Release (Projected)
Today	MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q1 2024 Earnings Release
29/04/2024 12:00	WUXI APPTEC CO., LTD.: Q1 2024 Earnings Release
28/04/2024	INVENTISBIO CO., LIMITED: Q1 2024 Earnings Release
28/04/2024	HITGEN INC.: Q1 2024 Earnings Release (Projected)
28/04/2024	DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
28/04/2024	CASSAVA SCIENCES, INC.: Q1 2024 Earnings Release (Projected)
27/04/2024	SHANGHAI MEDICILON INC.: Q1 2024 Earnings Release
25/04/2024	INVENTISBIO CO., LIMITED: Q4 2023 Earnings Release